Condition: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries · Obese · Sponsor: University of Colorado, Denver
Girls and women 12-35 years old with obesity and polycystic ovarian syndrome who are on or off metformin, will receive a glucagon like peptide-1 receptor agonist intervention for 10 months to induce metabolic changes, weight loss and improve reproductive abnormalities.
This description comes directly from the study's public registry record.
Yesenia Garcia-Reyes, MS · 720-777-6984 · PCOSresearch@cuanschutz.edu
Always discuss trial participation with your own doctor first.
| University of Colorado Anschutz/Children's Hospital Colorado Aurora | Aurora, Colorado, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05819853